Ardelyx (NASDAQ: ARDX) investor files to sell 50,000 shares under Rule 144
Rhea-AI Filing Summary
Ardelyx stockholder plans to sell shares under Rule 144. A notice was filed for the planned sale of 50,000 shares of Ardelyx common stock through Morgan Stanley Smith Barney LLC on or around 01/08/2026, listed with an aggregate market value of $291,500. The shares are to be sold on the NASDAQ, and the filing shows total Ardelyx shares outstanding of 242,974,306.
The 50,000 shares were acquired the same day, 01/08/2026, via a cash exercise of stock options granted by the issuer. The filing also reports that Laura A. Williams sold 6,426 Ardelyx common shares in a prior transaction on 11/21/2025 for gross proceeds of $35,580.12. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about the company.
Positive
- None.
Negative
- None.
FAQ
What does the Ardelyx (ARDX) Form 144 filing disclose?
Who is the seller named in the recent Ardelyx (ARDX) transactions?
What representation does the Ardelyx (ARDX) seller make in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.